Prosecution Insights
Prosecution Insights
19 pending office actions • 11 art units • 15 examiners • 0 of 19 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (32%) |
| §112 only | 2 (11%) |
| No statute on record | 11 (58%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VAN DRUFF, SYDNEY | 3 | 57.2% | +28.5% |
| GALSTER, SAMUEL LEONARD | 2 | 53.8% | +39.1% |
| SKOKO III, JOHN JOSEPH | 2 | 52.8% | +58.4% |
| JUEDES, AMY E | 1 | 44.5% | +41.0% |
| LIU, TRACY | 1 | 54.9% | +28.0% |
| ANTHOPOLOS, PETER | 1 | 57.2% | +58.8% |
| MILLER, DALE R | 1 | 62.3% | +16.5% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.4% |
| TATGE, LEXUS MARC | 1 | — | — |
| ISMAIL, REHANA | 1 | 78.9% | +30.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18016864 | COMBINATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE WITH HER DIMERIZATION INHIBITOR | SKOKO III, JOHN JOSEPH | 71d overdue |
| 18767925 | METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY | JUEDES, AMY E | 45d overdue |
| 18272050 | ANTI-DLL3 ANTIBODY-DRUG CONJUGATE | PUTTLITZ, KARL J | 36d overdue |
| 17262590 | EFFECTIVE METHOD FOR MANUFACTURING ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 2d overdue |
| 18263124 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | GALSTER, SAMUEL LEONARD | 6d |
| 18367446 | METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 22d |
| 18252838 | COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE | GALSTER, SAMUEL LEONARD | 22d |
| 17058838 | TREATMENT OF HER2-MUTATED CANCER BY ADMINISTERING ANTI-HER2 ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 27d |
| Art Unit | Apps |
|---|---|
| 1643 | 5 |
| 1693 | 3 |
| 1614 | 2 |
| 1642 | 2 |
| 1644 | 1 |
| 1611 | 1 |
| 1646 | 1 |
| 1637 | 1 |
| 1625 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18767925 | METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY | JUEDES, AMY E | 1644 | §112 | Final Rejection | 45d overdue | Pending | Jul 09, 2024 |
| 18708875 | PHARMACEUTICAL COMPOSITION HAVING EXCELLENT DISSOLUTION PROPERTIES | LIU, TRACY | 1614 | §103 | Non-Final OA | 62d | Pending | May 09, 2024 |
| 18561804 | HPV INFECTIOUS DISEASE VACCINE | ANTHOPOLOS, PETER | 1611 | Other | Non-Final OA | 46d | Pending | Nov 17, 2023 |
| 18367446 | METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 1643 | Other | Non-Final OA | 22d | Pending | Sep 12, 2023 |
| 18549797 | NOVEL DEALKOXYPHENYLATION REACTION | MILLER, DALE R | 1693 | Other | Non-Final OA | 33d | Pending | Sep 08, 2023 |
| 18263124 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | GALSTER, SAMUEL LEONARD | 1693 | §103 | Non-Final OA | 6d | Pending | Jul 26, 2023 |
| 18272050 | ANTI-DLL3 ANTIBODY-DRUG CONJUGATE | PUTTLITZ, KARL J | 1646 | Other | Non-Final OA | 36d overdue | Pending | Jul 12, 2023 |
| 18265756 | STABLE TARGET-EDITING GUIDE RNA TO WHICH CHEMICALLY MODIFIED NUCLEIC ACID IS INTRODUCED | TATGE, LEXUS MARC | 1637 | §103 | Non-Final OA | 36d overdue | Pending | Jun 07, 2023 |
| 18252838 | COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE | GALSTER, SAMUEL LEONARD | 1693 | §103 | Final Rejection | 22d | Pending | May 12, 2023 |
| 18249421 | METHOD OF PRODUCING 3-METHYL-4-HALO-INDOLE DERIVATIVE | ISMAIL, REHANA | 1625 | §112 | Non-Final OA | 35d | Pending | Apr 18, 2023 |
| 18025896 | A Scoring Method for an Anti-HER2 Antibody-Drug Conjugate Therapy | LU, CHENG | 1642 | Other | Non-Final OA | 21d | Pending | Mar 11, 2023 |
| 18016864 | COMBINATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE WITH HER DIMERIZATION INHIBITOR | SKOKO III, JOHN JOSEPH | 1643 | Other | Non-Final OA | 71d overdue | Pending | Jan 18, 2023 |
| 18012900 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATM INHIBITOR | STONEBRAKER, ALYSSA RAE | 1642 | Other | Final Rejection | 15d | Pending | Dec 23, 2022 |
| 17787760 | FILM-COATED TABLETS HAVING SMOOTH SURFACE | KNIGHT, SAMANTHA JO | 1614 | Other | Final Rejection | 32d overdue | Pending | Jun 21, 2022 |
| 17769483 | METHOD FOR PRODUCING BICYCLIC PHOSPHORAMIDITE | LEWIS, PATRICK T | 1691 | §103 | Non-Final OA | 139d overdue | Pending | Apr 15, 2022 |
| 17312084 | COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH PARP INHIBITOR | SKOKO III, JOHN JOSEPH | 1643 | Other | Final Rejection | 54d | Pending | Jun 09, 2021 |
| 17262590 | EFFECTIVE METHOD FOR MANUFACTURING ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 1643 | §103 | Non-Final OA | 2d overdue | Pending | Jan 22, 2021 |
| 17058838 | TREATMENT OF HER2-MUTATED CANCER BY ADMINISTERING ANTI-HER2 ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 1643 | Other | Final Rejection | 27d | Pending | Nov 25, 2020 |
| 16640914 | ANTIBODY-DRUG CONJUGATE PREPARATION AND LYOPHILIZATION FOR SAME | KIM, YUNSOO | 1641 | Other | Non-Final OA | 81d overdue | Pending | Feb 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial